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418 ABSTRACTS / Developmental Biology 306 (2007) 411–426tetralogy of Fallot. Conclusion: The most susceptible period in
the rat at the toxicity by FA deficiency induced by MTX was in
the 9th and 10th day and at dose of 0.25 and 0.5 mg/kg. The
deficiency of FA is a risk factor for develop CHD. The
proportion obtained for CHD was 16% and a ratio of 1:5. This
study gives a useful model for damage mechanisms experi-
mentation produces for FA deficit.
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The Notch and TGF-β signaling pathways have been shown
to play important roles in regulating endothelial-to-mesenchy-
mal transition (EMT). This process is required during cardiac
cushion development and generates cells that contribute to the
connective tissue of the valves and septa of the adult heart. We
show that the Notch pathway, via CSL, directly binds and
regulates expression of the Snail2 promoter in endothelial cells.
We show that Snail2 is required for Notch mediated EMT, binds
to and represses the VE-cadherin promoter, and induces a motile
phenotype. While Notch does not directly regulate Snail1
expression, Notch and TGF-β act synergistically to regulate
expression of Snail1 in endothelial cells. Additionally we
demonstrate that Snail2 is expressed by the mesenchymal cells
and a subset of endocardial cells of the atrioventricular canal and
outflow tract during cardiac morphogenesis. Our data demon-
strate that Snail2-deficient mouse embryos display defects in the
initiation of cardiac cushion EMT at E9.5, which can be rescued
by exogenous TGF-β2. Snail2-deficiency is compensated for by
increased Snail1 expression after E9.5, restoring EMT and
allowing cardiac cushion EMT. Collectively our data demon-
strate that Notch signaling directly regulates Snail2, but not
Snail1, expression and that the combined expression of Snail2
and Snail1 is required for cardiac cushion morphogenesis.
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achieved, is regulated by the pacemaker located within the sinus
node. Several molecular markers have been used to characterize
the sinus node. However, few genes so far described are
involved in its differentiation. Targeted mutation in the Short
stature homeobox gene 2 (Shox2) leads to cardiac edema and
irregular heart beat. Shox2 is expressed in the venous-atrial
junction (sinus node) beginning at E8.5, and the pattern remains
through embryogenesis. By E10.5 the venous valves of the
sinus node are forming and Shox2 expression extends to these
regions, also comprising the cardiac pacemaker. Shox2 null
mutation showed embryonic lethality around E11.5 and
histological analysis demonstrated that it leads to the formation
of hypoplastic venous valves, which likely results from a
decreased level of cell proliferation. In situ hybridization
showed a down-regulation of the pacemaker marker Hcn4, the
conduction system marker Tbx3, and the gap junction protein
Cx43 in the Shox2 mutant pacemaker region and venous
valves. Accordingly, ANF, a direct Tbx3 downstream target is
up-regulated. In contrast, the expression of the myogenic
differentiation markers, MLC2a, MLC2v, and cTnt is not
altered. Our results reveal an expression pattern of Shox2 in
the developing heart, restricted to the sinus venosus region,
including the pacemaker area. Histological analysis along with
that of molecular markers indicates that Shox2 plays a critical
role in the development and differentiation of pacemaker
cardiomyocytes.
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Transforming Growth Factor Beta (TGFβ) Receptor III
(TGFβR3) binds all 3 TGFβ ligands and inhibin with high
affinity but lacks the serine/threonine kinase domain found in the
Type I and Type II receptors (TGFβR1, TGFβR2). TGFβR3
facilitates signaling via TGFβR1/TGFβR2 but also plays a
unique and nonredundant role in TGFβ signaling. Deletion of
Tgfbr3 revealed a requirement for Tgfbr3 during development
of the coronary vessels. Coronary vasculogenesis is significantly
impaired in null mice with few vessels evident and numerous,
persistent blood islands found throughout the epicardium.
Tgfbr3 null mice die at E14.5, the time when functional coro-
nary vasculature is required for embryo viability. However, in
null mice nascent coronary vessels attach to the aorta, form two
coronary ostia, and initiate smooth muscle recruitment by E14.
Analysis of earlier developmental stages revealed defects in the
epicardium. At E13.5 these defects include an irregular and
